Elicio Therapeutics (ELTX) Q3 2025 Earnings

7AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-1.39
-1.14
-0.89
-0.64

Details

Expected EPS
-0.685
Actual EPS
-0.66
Surprise EPS
0.03
Surprise Percent
+3.65%

Description

Elicio Therapeutics (ELTX) has reported earnings of -0.66 per share for Q3 2025.

0 Comments

Share your thoughts